Navigation Links
McDavid® Patella Knee Support

ProductsMcDavid® Patella Knee Support
Company AliMed, Inc.
Item McDavid® Patella Knee Support
Features 
  • Helps relieve the symptoms of chondromalacia patellar subluxation and patellar tendonitis
  • Features two medial and two lateral spring-steel stays
  • 3/16" thick neoprene long sleeve
  • Nylon on both sides
  • Black
    • Description McDavid® Patella Knee Support helps relieve the symptoms of chondromalacia patellar subluxation and patellar tendonitis. Features two medial and two lateral spring-steel stays. 3/16" thick neoprene long sleeve. Nylon on both sides. Black.
    Info AliMed, Inc.
    Customer Service: (800) 225-2610
    Web site: http://www.alimed.com/

    Related medicine products :

    1. McDavid® Pro Knee Stabilizer
    2. Genesis II Patellar Instruments
    3. 13 Patella Stabilizer w/Cor-Trak Buttress
    4. Patellar Brace
    5. Extensor™ Patellar Knee Support with Lateral Strap
    6. Extensor™ Patellar Knee Support with Popliteal Cutout
    7. Dytex Adjustable Patella Donut
    8. Budde Halo Side Rail Support
    9. Fort Moderate Support
    10. Trooper Extra Support Guide Wire
    11. BVS 5000 Biventricular Support System
    Lab-Reader
    Fully automatic NRTL and CE certified microplate reader.
    Chameleon is a compact and versatile multilabel microplate reader. The patented optical design allows up to six measurement technologies including liquid scintillation counting, luminescence, absorba
    Elisa strip reader for single strips or break-away format. On board software calculates single & multi-point calibration curves, regressions, & a variety of cutoff.
    Medicine Products:
    (Date:7/3/2009)... In response to breaking news of drugs reportedly ... American Society of Anesthesiologists releases th...y of Anesthesiologists (ASA), which is made up of ...re, does not know the specific circumstances surro...nequivocally maintains that Diprivan, or its gener...
    (Date:7/3/2009)...d recognise service excellence during National Cus... London (PRWeb UK) July 3, 2009 -- Comp...g urged to celebrate the importance of excellent c...r Service Week - 5-11 October., , ,Employers in al... shop and local authority see the week, which is o...
    (Date:7/3/2009)...wswire/ -- Bertalan Mesko, medical blogger and hea...or medical professionals focusing on how the virtu...nces are expensive and patients are also open to u...ps doctors enter a virtual realm and organize medi...Life provides opportunities for case presentations...
    (Date:7/3/2009)... death in middle age may triple the risk, study sh...) -- Middle-aged adults who live alone are twice a...e later in life compared to those who are married ...s higher among those who are divorced or widowed, ...searchers. , The study included 2,000 men and w...
    Breaking Medicine News(10 mins):Health News:American Society of Anesthesiologists Releases Following Statement Related to Media Inquires Regarding Michael Jackson's Death 2Health News:Businesses Urged to Sign Up and Celebrate Customer Service 2Health News:Living Alone Increases Odds of Developing Dementia 2
    ...next?' is a question that enters the minds of many... to reorder itself and adjust into what policy mak...need to stay informed and become empowered self-ad...ensure quality-of-life. This national movement, co...
    ...nya disease is now reported to have spread in abou...people.// Though the disease is not fatal it weak...tious diseases. It was first reported in Tasmania.... Mundada said that he would launch an awareness pr...
    ...ons have died of AIDS in the district in past two ...ntified this month, an official said today. // Th...identified in the district while six persons died ...ths, Chief Medical Superintendent Rajni Kant Gupta...
    ...e drug is beginning to light up the lives of thous...o severe cancers of the kidney and the gut.// Init...ts future use in breast, lung and pancreatic cance...ed as the “smart” drug works by nipping an importa...
    Other Medicine News:Health News:New Music Project Promotes Quality-of-Life After Cancer 2
    (Date:7/3/2009)... -- BioCis Pharma Ltd., a privately,held drug dev...inland,announced positive results from its Phase...am, the company,s novel topical drug for dermatolo...conducted in Finland, included 13,patients with m...ProtoCure,emulsion cream to the affected skin are...
    (Date:7/2/2009)... Eisai Co., Ltd. (Headquarters: Tok... Eisai Corporation of North America (Headquarters:...zu) are currently focusing on three clinical devel...icept(R) (donepezil hydrochloride tablets) to furt...e. As progress in those programs has been made, Ei...
    (Date:6/30/2009)...-- If you have been eating Garlic to keep the mosq...ere is absolutely no scientific evidence that eati... garlic has plenty of evidence to prove it keeps t...y lawns is not as strange as it seems. Mosquito Ba...s being used successfully by city parks, golf cour...
    (Date:6/30/2009)...all/ -- Cephalon, Inc. (Nasdaq: CEPH ) today ann...ug Application (sNDA) to the U.S. Food and Drug Ad...R) (armodafinil) Tablets [C-IV] for the indication...e sleepiness associated with jet lag disorder resu...an acute condition that occurs when a person,s int...
    Breaking Medicine Technology:BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis 2Current Status of the Development Programs of New Indications and Formulations for Aricept(R) for Enhancing Patient Value 2Current Status of the Development Programs of New Indications and Formulations for Aricept(R) for Enhancing Patient Value 3Keep Mosquitoes and More Out of Your Yard with Garlic From Garlic Research Labs, Inc. 2Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 2Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 3Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 4SENOMYX ANNOUNCES THE EXTENSION OF ITS COLLABORATIVE RESEARCH DEVELOPMENT COMMERCIALIZATION AND LICENSE AGREEMENT WITH AJINOMOTO CO INC 11181 1SENOMYX ANNOUNCES THE EXTENSION OF ITS COLLABORATIVE RESEARCH DEVELOPMENT COMMERCIALIZATION AND LICENSE AGREEMENT WITH AJINOMOTO CO INC 11181 2SENOMYX ANNOUNCES THE EXTENSION OF ITS COLLABORATIVE RESEARCH DEVELOPMENT COMMERCIALIZATION AND LICENSE AGREEMENT WITH AJINOMOTO CO INC 11181 3How Long Will the Economic Downturn Affect the Dental Biomaterials Market 3F 11179 1How Long Will the Economic Downturn Affect the Dental Biomaterials Market 3F 11179 2Anesthesia in Youngest Kids May be Linked to Learning Disabilities 40452 1Anesthesia in Youngest Kids May be Linked to Learning Disabilities 40452 2Anesthesia in Youngest Kids May be Linked to Learning Disabilities 40452 3Just Say No To Charcoal 21 New Eco Friendly Alternative Grills Faster Burns Cleaner And Greener 11178 1Just Say No To Charcoal 21 New Eco Friendly Alternative Grills Faster Burns Cleaner And Greener 11178 2
    ...ass.--(BUSINESS WIRE)--Jul 6, 2007 - BusinessWeek ...pharmaceutical and,biotechnology companies to be f...treatment for cardiovascular disease. While,angiog...is, Boston,Scientific, Baxter, and Genzyme, among ...w biological therapy for advanced,coronary artery ...
    ..., N.J., July 05, 2007 /PRNewswire/ -- Results from... open-label, Phase,3 study showed that 77 percent ...ing PREZISTA(TM) (darunavir) 600 mg tablets with,1...optimized,background regimen (OBR) of antiretrovir...00 copies/mL at week 48, compared to 68,percent of...
    Other Medicine Technology:BusinessWeek Article Highlights Promising Breakthrough Treatment,for Advanced Coronary Artery Disease 2New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 2New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 3New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 4New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 5New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 6New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 7New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 8